Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “asthma”

Tapering of Inhaled Corticosteroids in Tezepelumab-treated Asthma patieNts: Impact on Clinical OutcomesEnrolling By Invitation
NCT07713498N/AUpdated Jul 21, 2026
Sponsor: Franciscus Gasthuis
Severe Asthma
Netherlands
VR vs Treadmill Exercise in Children With AsthmaRecruiting
NCT07610447NAUpdated Jul 21, 2026
Sponsor: Bezmialem Vakif University
Asthma (Diagnosis)
Turkey (Türkiye)
Comparison of Box Breathing and Rhythmic Breathing Techniques in Patients With AsthmaNot Yet Recruiting
NCT07717476NAUpdated Jul 21, 2026
Sponsor: Riphah International University
Asthma (Diagnosis)
Pakistan
Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With AsthmaRecruiting
NCT07665892Phase 1Updated Jul 21, 2026
Sponsor: Aspeya, Inc.
Safety in Asthma Patients
United States
Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)Not Yet Recruiting
NCT07191535Phase 2Updated Jul 20, 2026
Sponsor: Foresee Pharmaceuticals Co., Ltd.
Asthma (Diagnosis) · Pulmonary Function · Moderate-to-Severe Asthma
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)Recruiting
NCT07359846Phase 3Updated Jul 20, 2026
Sponsor: Generate Biomedicines
Severe Asthma
United States, Argentina, Belgium, Japan, Serbia +1 more
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced WheezingRecruiting
NCT03889743Phase 4Updated Jul 20, 2026
Sponsor: St. Olavs Hospital
Asthma · Inflammation
Finland, Norway, Sweden
Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in ItalyActive Not Recruiting
NCT06948396N/AUpdated Jul 20, 2026
Sponsor: AstraZeneca
Asthma
Italy
Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)Completed
NCT04550962N/AUpdated Jul 20, 2026
Sponsor: Sanofi
Asthma
Argentina, Chile, Colombia, Israel, Kuwait +7 more
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)Recruiting
NCT07276724Phase 3Updated Jul 20, 2026
Sponsor: Generate Biomedicines
Severe Asthma
United States, Bulgaria, Germany, Hungary, Latvia +1 more
Comparative Real World Effectiveness of SQ Sublingual Immunotherapy (SLIT)-Tablets vs. Controls in Allergic Rhinitis and AsthmaCompleted
NCT05476484N/AUpdated Jul 20, 2026
Sponsor: ALK-Abelló A/S
Allergic Rhinitis · Asthma · Allergy
Denmark
A Study Testing the Superiority of CHF 1535 pMDI 800/24µg Total Daily Dose Compared With CHF 718 pMDI 800µg Total Daily Dose in Adults With Asthma on Medium or High-Dose Inhaled CorticosteroidCompleted
NCT05292586Phase 3Updated Jul 20, 2026
Sponsor: Chiesi Farmaceutici S.p.A.
Asthma
United States
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsRecruiting
NCT06932263Phase 2Updated Jul 20, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, Brazil, Chile, China +16 more
A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65Active Not Recruiting
NCT07060885Phase 3Updated Jul 20, 2026
Sponsor: ALK-Abelló A/S
Allergic Rhinoconjunctivitis · Allergic Rhinitis
China
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic AsthmaActive Not Recruiting
NCT05692180Phase 3Updated Jul 17, 2026
Sponsor: AstraZeneca
Asthma
United States, Argentina, France, Italy, Poland +4 more
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-UpRecruiting
NCT06732414N/AUpdated Jul 17, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Allergy, Sinus Disorders, Atopic Diseases, Asthma, Allergic Rhinitis, Atopic Dermatitis, EoE, Drug a
United States
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller MedicationCompleted
NCT01867125Phase 3Updated Jul 17, 2026
Sponsor: Hoffmann-La Roche
Asthma
United States, Argentina, Australia, Belgium, Canada +21 more
A Comparative Study to Investigate the Difference in Blood Levels of Two Different Formulations of GSK5784283Not Yet Recruiting
NCT07712393Phase 1Updated Jul 17, 2026
Sponsor: GlaxoSmithKline
Asthma
PULmonary Stimulation for Asthma ReliefNot Yet Recruiting
NCT07709754NAUpdated Jul 17, 2026
Sponsor: Spiro Medical, Inc.
Moderate to Severe Asthma
United States
Activation and Function of Eosinophils in Conditions With Blood or Tissue EosinophiliaRecruiting
NCT00001406N/AUpdated Jul 17, 2026
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Immune System Diseases · Eosinophilia · Helminthiasis · Hypersensitivity
United States
Role of Genetic Factors in the Development of Lung DiseaseRecruiting
NCT00001532N/AUpdated Jul 17, 2026
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Cystic Fibrosis · Pulmonary Fibrosis · Tuberous Sclerosis · Asthma
United States
NHALES (Natural History of Asthma With Longitudinal Environmental Sampling)Recruiting
NCT02327897N/AUpdated Jul 17, 2026
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Asthma
United States
A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate AsthmaCompleted
NCT02104674Phase 3Updated Jul 17, 2026
Sponsor: Hoffmann-La Roche
Asthma
United States, Brazil, Bulgaria, Canada, Czechia +6 more
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)Recruiting
NCT06705764Phase 4Updated Jul 17, 2026
Sponsor: University of Alberta
Severe Asthma
Canada
Study of the Effect of Innate on the Inflammatory Response to EndotoxinRecruiting
NCT01143480N/AUpdated Jul 16, 2026
Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Asthma · Atherosclerosis · Metabolic Syndrome · Insulin Resistance
United States

Previous page Next page